{
  "overview": "Amgen is a pioneering American multinational biopharmaceutical company ranked 18th among the largest biomedical companies by revenue, specializing in developing biologic medicines from living cells.",
  "industry": "Biopharmaceutical/Biotechnology",
  "size": "Large multinational (likely 20,000+ employees)",
  "culture_signals": [
    "Strong patient-focused mission and values",
    "Beautiful campus environment",
    "Managers exemplify company values",
    "Collaborative work environment with knowledgeable colleagues",
    "Emphasis on work-life balance and flexibility"
  ],
  "recent_news": [
    "Acquired Dark Blue Therapeutics to strengthen oncology pipeline (2026)",
    "European Commission approved UPLIZNA for generalized myasthenia gravis (February 2026)",
    "Scheduled Q4 2025 earnings announcement for February 3, 2026"
  ],
  "interview_talking_points": [
    "Company's pioneering role in biotechnology and use of living cells for medicine",
    "Recent expansion in oncology through Dark Blue Therapeutics acquisition",
    "Strong focus on rare diseases and unmet medical needs",
    "Company name origin: AMGen from 'Applied Molecular Genetics'",
    "Therapeutic focus areas: cancer, heart disease, osteoporosis, inflammatory and rare diseases"
  ],
  "potential_concerns": [
    "Large corporate environment may have bureaucracy",
    "Competitive biotech industry with regulatory challenges",
    "No specific concerns identified in available data"
  ],
  "glassdoor_sentiment": "positive",
  "growth_trajectory": "growing"
}